Cargando…
Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study
Non-fasting lipidemia (nFL), mainly contributed by postprandial lipidemia (PL), has recently been recognized as an important cardiovascular disease (CVD) risk as fasting lipidemia (FL). PL serves as a common feature of dyslipidemia in Type 2 Diabetes (T2D), albeit effective therapies targeting on PL...
Autores principales: | Wang, Shujie, Ren, Huahui, Zhong, Huanzi, Zhao, Xinjie, Li, Changkun, Ma, Jing, Gu, Xuejiang, Xue, Yaoming, Huang, Shan, Yang, Jialin, Chen, Li, Chen, Gang, Qu, Shen, Liang, Jun, Qin, Li, Huang, Qin, Peng, Yongde, Li, Qi, Wang, Xiaolin, Zou, Yuanqiang, Shi, Zhun, Li, Xuelin, Li, Tingting, Yang, Huanming, Lai, Shenghan, Xu, Guowang, Li, Junhua, Zhang, Yifei, Gu, Yanyun, Wang, Weiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726654/ https://www.ncbi.nlm.nih.gov/pubmed/34923903 http://dx.doi.org/10.1080/19490976.2021.2003176 |
Ejemplares similares
-
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
por: Zhang, Yifei, et al.
Publicado: (2020) -
The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function
por: Cheng, Tingting, et al.
Publicado: (2022) -
Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
por: Gu, Yanyun, et al.
Publicado: (2017) -
Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine
por: Wang, Yan, et al.
Publicado: (2017) -
Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
por: Chen, Yuting, et al.
Publicado: (2022)